- Home
- CPHI vs ONFO Comparison
CPHI vs ONFO Comparison
Compare CPHI & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHI
- ONFO
- Stock Information
- Founded
- CPHI N/A
- ONFO 2018
- Country
- CPHI China
- ONFO United States
- Employees
- CPHI N/A
- ONFO N/A
- Industry
- CPHI Biotechnology: Pharmaceutical Preparations
- ONFO Computer Software: Programming Data Processing
- Sector
- CPHI Health Care
- ONFO Technology
- Exchange
- CPHI Nasdaq
- ONFO Nasdaq
- Market Cap
- CPHI 5.3M
- ONFO 5.4M
- IPO Year
- CPHI N/A
- ONFO 2022
- Fundamental
- Price
- CPHI $1.43
- ONFO $1.04
- Analyst Decision
- CPHI
- ONFO
- Analyst Count
- CPHI 0
- ONFO 0
- Target Price
- CPHI N/A
- ONFO N/A
- AVG Volume (30 Days)
- CPHI 90.2K
- ONFO 57.3K
- Earning Date
- CPHI 08-26-2025
- ONFO 08-14-2025
- Dividend Yield
- CPHI N/A
- ONFO N/A
- EPS Growth
- CPHI N/A
- ONFO N/A
- EPS
- CPHI N/A
- ONFO N/A
- Revenue
- CPHI $4,396,201.00
- ONFO $10,508,728.00
- Revenue This Year
- CPHI N/A
- ONFO N/A
- Revenue Next Year
- CPHI N/A
- ONFO N/A
- P/E Ratio
- CPHI N/A
- ONFO N/A
- Revenue Growth
- CPHI N/A
- ONFO 78.36
- 52 Week Low
- CPHI $1.20
- ONFO $0.61
- 52 Week High
- CPHI $3.35
- ONFO $1.88
- Technical
- Relative Strength Index (RSI)
- CPHI 36.67
- ONFO 45.84
- Support Level
- CPHI $1.29
- ONFO $0.94
- Resistance Level
- CPHI $1.52
- ONFO $1.26
- Average True Range (ATR)
- CPHI 0.13
- ONFO 0.11
- MACD
- CPHI -0.02
- ONFO -0.02
- Stochastic Oscillator
- CPHI 22.22
- ONFO 27.75
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.